Bao Duong
Nkarta Therapeutics (United States)(US)
Publications by Year
Research Areas
Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, NF-κB Signaling Pathways, Cell death mechanisms and regulation
Most-Cited Works
- → Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling(2006)570 cited
- → The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis(2015)275 cited
- → A20 Restricts Ubiquitination of Pro-Interleukin-1β Protein Complexes and Suppresses NLRP3 Inflammasome Activity(2015)264 cited
- → Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo(2009)172 cited
- → High-Affinity Ligand Probes of CD22 Overcome the Threshold Set by cis Ligands to Allow for Binding, Endocytosis, and Killing of B Cells(2006)147 cited
- → Expression Profiling of Neural Cells Reveals Specific Patterns of Ethanol-Responsive Gene Expression(2000)122 cited
- → ΔBAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models(2005)111 cited
- → Basal B Cell Receptor-Directed Phosphatidylinositol 3-Kinase Signaling Turns Off RAGs and Promotes B Cell-Positive Selection(2007)98 cited
- → Regulation of the B Cell Receptor Repertoire and Self-Reactivity by BAFF(2010)90 cited
- → A Role for Nuclear Factor Kappa B/Rel Transcription Factors in the Regulation of the Recombinase Activator Genes(2005)82 cited